Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |